Home » Topics » Regulatory » Patents

Patents
RSS

Cytokine inhibitors in development at Sumitomo for AIDS and other disorders

Feb. 5, 1999

Modulators of nAChR a focus of research at NeuroSearch

Feb. 5, 1999

New Celgene compounds reduceTNF-alpha levels and NF-kB activity

Feb. 5, 1999

1,6-Naphthyridine anticonvulsants in research at SmithKline Beecham

Feb. 4, 1999

Preparation and use of nAChR modulators disclosed by NeuroSearch

Feb. 4, 1999

Roche patents novel compounds interacting with group II mGluR

Feb. 4, 1999

New GABA-A receptor ligands for anxiety, convulsions

Feb. 4, 1999

Production and use of KSHVIL-6/vMIP-1alpha II peptides, antibodies and antisense oligonucleotides

Feb. 4, 1999

N- and L-type calcium channel inhibitors developed by Ajinomoto

Feb. 4, 1999

Bayer describes production and use of 2,9-disubstituted purin-6-ones

Feb. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...